HTA4 Clinical Development and HTA Approval of MULTI-Indication Oncology Products: Evidence from Germany, France, England, Scotland, the US, Canada, and Australia
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.034
https://www.valueinhealthjournal.com/article/S1098-3015(20)32290-7/fulltext
Title :
HTA4 Clinical Development and HTA Approval of MULTI-Indication Oncology Products: Evidence from Germany, France, England, Scotland, the US, Canada, and Australia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32290-7&doi=10.1016/j.jval.2020.08.034
First page :
Section Title :
Open access? :
No
Section Order :
10022